Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 36
2015 258
2016 306
2017 299
2018 281
2019 263
2020 264
2021 197
2022 114
2023 108
2024 61

Text availability

Article attribute

Article type

Publication date

Search Results

1,832 results

Results by year

Filters applied: . Clear all
Page 1
Infliximab-Related Infusion Reactions: Systematic Review.
Lichtenstein L, Ron Y, Kivity S, Ben-Horin S, Israeli E, Fraser GM, Dotan I, Chowers Y, Confino-Cohen R, Weiss B. Lichtenstein L, et al. J Crohns Colitis. 2015 Sep;9(9):806-15. doi: 10.1093/ecco-jcc/jjv096. Epub 2015 Jun 19. J Crohns Colitis. 2015. PMID: 26092578 Free PMC article. Review.
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
Syversen SW, Jørgensen KK, Goll GL, Brun MK, Sandanger Ø, Bjørlykke KH, Sexton J, Olsen IC, Gehin JE, Warren DJ, Klaasen RA, Noraberg G, Bruun TJ, Dotterud CK, Ljoså MKA, Haugen AJ, Njålla RJ, Zettel C, Ystrøm CM, Bragnes YH, Skorpe S, Thune T, Seeberg KA, Michelsen B, Blomgren IM, Strand EK, Mielnik P, Torp R, Mørk C, Kvien TK, Jahnsen J, Bolstad N, Haavardsholm EA. Syversen SW, et al. JAMA. 2021 Dec 21;326(23):2375-2384. doi: 10.1001/jama.2021.21316. JAMA. 2021. PMID: 34932077 Free PMC article. Clinical Trial.
Successful treatment of PD-1 inhibitor-induced psoriasis with infliximab.
Hansen I, Heidrich I, Abeck F, Kött J, Booken N, Gebhardt C, Schneider SW. Hansen I, et al. J Eur Acad Dermatol Venereol. 2023 May;37(5):e621-e623. doi: 10.1111/jdv.18780. Epub 2022 Nov 30. J Eur Acad Dermatol Venereol. 2023. PMID: 36424911 No abstract available.
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial.
Louis E, Resche-Rigon M, Laharie D, Satsangi J, Ding N, Siegmund B, D'Haens G, Picon L, Bossuyt P, Vuitton L, Irving P, Viennot S, Lamb CA, Pollok R, Baert F, Nachury M, Fumery M, Gilletta C, Almer S, Ben-Horin S, Bouhnik Y, Colombel JF, Hertervig E; GETAID and the SPARE-Biocycle research group. Louis E, et al. Lancet Gastroenterol Hepatol. 2023 Mar;8(3):215-227. doi: 10.1016/S2468-1253(22)00385-5. Epub 2023 Jan 11. Lancet Gastroenterol Hepatol. 2023. PMID: 36640794 Free PMC article. Clinical Trial.
SB2: An Infliximab Biosimilar.
Lamb YN, Scott LJ, Deeks ED. Lamb YN, et al. BioDrugs. 2017 Oct;31(5):461-464. doi: 10.1007/s40259-017-0240-7. BioDrugs. 2017. PMID: 28803431 Review.
[Infliximab].
Goujon C, Bachelez H; Groupe de recherche sur le psoriasis de la Société française de dermatologie. Goujon C, et al. Ann Dermatol Venereol. 2019 Jun-Jul;146(6-7):483-486. doi: 10.1016/j.annder.2019.04.013. Epub 2019 Jun 20. Ann Dermatol Venereol. 2019. PMID: 31230775 French. No abstract available.
Infliximab-induced autoimmune hepatitis.
Jenkins A, Austin A, Hughes K, Sadowski B, Torres D. Jenkins A, et al. BMJ Case Rep. 2021 May 24;14(5):e239944. doi: 10.1136/bcr-2020-239944. BMJ Case Rep. 2021. PMID: 34031069 Free PMC article.
Anti-TNF-alpha-induced lupus.
De Bandt M. De Bandt M. Arthritis Res Ther. 2019 Nov 12;21(1):235. doi: 10.1186/s13075-019-2028-2. Arthritis Res Ther. 2019. PMID: 31718696 Free PMC article. No abstract available.
1,832 results